U.S. and Israeli Strikes Expand to Iranian Civilian and Medical Infrastructure

As of April 5, 2026, U.S. and Israeli military operations against Iran have expanded to include critical civilian infrastructure, marking a departure from previous primary focuses on military and nuclear sites. Recent targets include the Pasteur Institute of Iran, a historic medical research center, and Tofigh Darou, a major pharmaceutical manufacturer. While Israeli officials have justified the pharmaceutical strikes by alleging the facilities contribute to chemical weapons research for the SPND nuclear program, the destruction has caused significant disruptions to the production of essential medicines such as anesthetics and anti-cancer drugs. The humanitarian impact intensified following a U.S. aerial strike on the B1 suspension bridge between Tehran and Karaj on April 2. The attack resulted in the deaths of at least eight civilians, including families celebrating the Nowruz holidays. President Trump described the expanded targeting as part of a "comprehensive pressure" campaign, stating in a recent televised address his intent to degrade Iran's essential infrastructure to the "Stone Ages." Economic and logistical disruptions are mounting as strikes also hit steel plants and key transport corridors leading to the Caspian Sea. Iranian media reports indicate that these actions are severely hindering the nation's industrial output and public health capabilities. While no new official statements have been released in the last 24 hours, the recent pattern of strikes suggests a coordinated allied strategy to weaken Iran's civilian and economic resilience.